Among the most important changes in the regulation of the Russian pharmaceutical industry in the 2nd quarter of 2023, are the following:
Among the most important changes in the regulation of foreign economic activity in the 1st quarter of 2023, the following can be distinguished:
Roman Shabrov, partner at BRACE commented for Pharmaceutical Bulletin magazine on the case of an anti-competitive agreement on the Chlorhexedine antiseptic market, identified by the FAS Russia, the resolution of which was appealed by the companies held liable.
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 1st quarter of 2023, the following can be distinguished:
In July 2021, the Eurasian Economic Commission issued an update that from July 1, 2021, medicinal products should be registered according to the unified rules of the EAEU. These rules were approved by the Decision of the Council of the Economic Commission dated 03.01.2017 No. 78 “On the rules for registration and examination of medicines for medical use”. At the same time, for the Russian Federation, the establishment of compulsory registration under the EAEU Rules was carried out from January 1, 2021.
- The Ministry of Health has allowed the use of personal medicines of patients in inpatient treatment
- Simplified medicinal product labeling procedure is prolonged
- A new regulation on state control of medicinal products circulation
- New rules for the import of medicinal products into the territory of Russia have been adopted